Article
This biotech startup is finding new cancer drugs with $75 million from General Catalyst. Here's the pitch deck Georgiamune used to raise its Series A.
Rating:
0.0
Views:
14
Likes:
1
Library:
1
Georgiamune is testing new drugs for cancer and autoimmune disorders with $75 million in Series A funding from investors like General Catalyst.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value